# A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)

> **NCT00943111** · PHASE3 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 160 (actual)

## Conditions studied

- Gaucher Disease, Type 1

## Interventions

- **DRUG:** Eliglustat tartrate
- **DRUG:** Imiglucerase

## Key facts

- **NCT ID:** NCT00943111
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-11
- **Final completion:** 2015-06
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2016-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00943111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00943111, "A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00943111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*